Renaissance Technologies - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 78 filers reported holding OCULAR THERAPEUTIX INC in Q4 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$393
+207.0%
125,200
+403.0%
0.00%
Q2 2023$128
-65.9%
24,893
-65.0%
0.00%
Q1 2023$375
-54.6%
71,193
-75.8%
0.00%
-100.0%
Q4 2022$826
-98.6%
293,993
+1887.4%
0.00%
Q3 2022$61,000
-96.0%
14,793
-96.1%
0.00%
-100.0%
Q2 2022$1,534,000
-39.3%
381,500
-25.3%
0.00%
-33.3%
Q1 2022$2,528,000
+353.0%
510,805
+537.7%
0.00%
+200.0%
Q4 2021$558,000
-77.3%
80,100
-67.5%
0.00%
-66.7%
Q3 2021$2,462,000
-46.9%
246,200
-24.7%
0.00%
-50.0%
Q2 2021$4,639,000
+466.4%
327,122
+555.6%
0.01%
+500.0%
Q1 2021$819,000
-88.2%
49,900
-85.1%
0.00%
-87.5%
Q4 2020$6,915,000
+738.2%
334,066
+275.8%
0.01%
+700.0%
Q1 2017$825,000
-32.0%
88,900
-38.7%
0.00%
-50.0%
Q4 2016$1,214,000
+418.8%
145,100
+206.8%
0.00%
Q2 2016$234,000
+1.3%
47,300
+330.3%
0.00%
-100.0%
Q2 2015$231,00010,9920.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2016
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders